Artificial Intelligence in Dermatology: Clinical Oversight and Governance Frameworks

Artificial intelligence is increasingly embedded in dermatology workflows—particularly in image-based and asynchronous care models. Its responsible integration requires more than technical validation; it requires structured physician oversight, defined escalation pathways, and formal governance frameworks. In pediatric and asynchronous settings, where image variability and incomplete history are common, these safeguards are not optional; they are foundational to responsible implementation.

Three areas require particular attention:

1. Diagnostic Risk in Image-Limited Settings
AI tools trained on curated datasets may not generalize to real-world, patient-submitted images. Oversight structures must account for spectrum bias and incomplete data.

2. Pediatric-Specific Safety Considerations
Children are not simply smaller adults. Escalation thresholds, medication safety, and rash differentials require fellowship-level nuance.

3. Governance & Escalation Criteria
AI-assisted triage must integrate defined escalation pathways to in-person evaluation. Clinical oversight cannot be optional or symbolic; governance must be operationalized within care pathways.

Who This Work Supports

• Digital health organizations implementing AI-assisted triage
• Telemedicine platforms integrating dermatologic decision-support tools
• Pediatric-inclusive product design teams
• Clinical governance committees
• Startups seeking physician oversight structures

Clinical Background

Anne Allen, MD, FAAD is a board-certified dermatologist with fellowship training in pediatric dermatology, licensed to practice medicine in all 50 U.S. states and Washington, DC.

Her work in physician-led asynchronous dermatology informs a clinical framework grounded in diagnostic caution, structured escalation, and pediatric safety. Her perspective emphasizes patient safety, diagnostic accuracy, and the continued role of physician judgment—particularly in asynchronous and pediatric-inclusive care models.

Dr. Allen is interested in collaborations related to clinical oversight, safety validation, pediatric-appropriate design, asynchronous care pathways, and regulatory-conscious implementation of digital health technologies.

For collaboration or advisory inquiries related to AI implementation, governance, or physician oversight frameworks, please use the contact form or connect via LinkedIn.

Selected Writing & Perspectives

Selected essays expanding on governance, pediatric safety, and diagnostic risk in AI-enabled dermatology:

AI in Dermatology Requires Physician Oversight
A discussion of real-world image variability, spectrum bias, and the structural role of escalation frameworks in AI-assisted dermatology.

Escalation Criteria in Pediatric Teledermatology
An outline of risk thresholds, age-specific safety considerations, and structured referral pathways in virtual pediatric care.

Diagnostic Risk in Asynchronous Dermatology
An examination of incomplete data environments, image-quality variability, and mitigation strategies in asynchronous workflows.